Untitled Episode
Listen now
Description
This Forum explored the challenges and complexities of drug trials, and how they impact disease treatment and prevention — particularly for conditions that currently have little or no therapeutic options. As a case study, the panel discussed Alzheimer’s and several drugs in development for that disease, but also addressed broader concerns related to the pharmaceutical testing pipeline for unmet medical needs as a whole. This event was presented April 15, 2016 in partnership with HHMI Tangled Bank Studios, in collaboration with STAT, and in association with NOVA.
Watch the entire series from The Forum at Harvard T.H. Chan School of Public Health at www.ForumHSPH.org.
More Episodes
More than 100 million Americans struggle with chronic pain, according to one Institute of Medicine estimate, at an annual cost of as much as $635 billion in treatment and lost productivity. Further, the misuse of potent opioid painkillers, while increasing risk of addiction and abuse, can confuse...
Published 11/14/16
Health care has emerged as a hotly debated issue of the 2016 presidential election, with the Republican and Democratic presidential nominees expressing starkly different views on the Affordable Care Act (ACA). While approximately 20 million people have gained healthcare coverage since the law’s...
Published 11/04/16
According to the CDC, nearly 29 million U.S. women and 16 million U.S. men have experienced severe physical violence by an intimate partner at some point in their lifetime. Most of those experiences occur before the age of twenty-five. The evidence is clear that domestic violence takes a physical...
Published 10/25/16
Links
Genres
Artwork or description wrong?
Request an update »
Updates may take a few minutes.
Do you host a podcast?
Track your ranks and reviews from Spotify, Apple Podcasts and more.
